Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ackerson

Showing results (461-470 of 488) with videos related to

Pageof 49
Sort By:
Lancet Regional Health. Americas|February 21, 2022
Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort studySara Y Tartof, Jeff M Slezak, Laura Puzniak, et al.
Annals of the Rheumatic Diseases|February 20, 2025
Effectiveness and safety of the recombinant zoster vaccine in individuals ≥50 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series studyEmily Rayens, Lina S Sy, Lei Qian, et al.
Journal of the American Geriatrics Society|August 16, 2014
Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the chronic renal insufficiency cohort cognitive studyKristine Yaffe, Manjula Kurella-Tamura, Lynn Ackerson, et al.
The Journal of Biological Chemistry|August 22, 2003
Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neuronsMatthew S Goldberg, Sheila M Fleming, James J Palacino, et al.
Human Vaccines & Immunotherapeutics|December 8, 2025
Effectiveness and safety of the recombinant zoster vaccine in adults aged ≥50 years with inflammatory bowel diseaseHung Fu Tseng, Lina S Sy, Emily Rayens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
Adjuvanted recombinant zoster vaccine is effective against herpes zoster ophthalmicus, and is associated with lower risk of acute myocardial infarction and stroke in adults aged ≥50 yearsEmily Rayens, Lina S Sy, Lei Qian, et al.
Journal of Child Neurology|November 17, 2012
Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States networkLaura Julian, Dana Serafin, Leigh Charvet, et al.
Nature Communications|January 12, 2023
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5Hung Fu Tseng, Bradley K Ackerson, Katia J Bruxvoort, et al.
Annals of Internal Medicine|August 14, 2020
Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care OrganizationSara Y Tartof, Lei Qian, Vennis Hong, et al.
Stroke|November 26, 2015
An International Standard Set of Patient-Centered Outcome Measures After StrokeJoel Salinas, Sara M Sprinkhuizen, Teri Ackerson, et al.
Pageof 49

Showing results (461-470 of 488) with videos related to

Sort By:
Pageof 49
Lancet Regional Health. Americas|February 21, 2022
Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort studySara Y Tartof, Jeff M Slezak, Laura Puzniak, et al.
Annals of the Rheumatic Diseases|February 20, 2025
Effectiveness and safety of the recombinant zoster vaccine in individuals ≥50 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series studyEmily Rayens, Lina S Sy, Lei Qian, et al.
Journal of the American Geriatrics Society|August 16, 2014
Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the chronic renal insufficiency cohort cognitive studyKristine Yaffe, Manjula Kurella-Tamura, Lynn Ackerson, et al.
The Journal of Biological Chemistry|August 22, 2003
Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neuronsMatthew S Goldberg, Sheila M Fleming, James J Palacino, et al.
Human Vaccines & Immunotherapeutics|December 8, 2025
Effectiveness and safety of the recombinant zoster vaccine in adults aged ≥50 years with inflammatory bowel diseaseHung Fu Tseng, Lina S Sy, Emily Rayens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
Adjuvanted recombinant zoster vaccine is effective against herpes zoster ophthalmicus, and is associated with lower risk of acute myocardial infarction and stroke in adults aged ≥50 yearsEmily Rayens, Lina S Sy, Lei Qian, et al.
Journal of Child Neurology|November 17, 2012
Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States networkLaura Julian, Dana Serafin, Leigh Charvet, et al.
Nature Communications|January 12, 2023
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5Hung Fu Tseng, Bradley K Ackerson, Katia J Bruxvoort, et al.
Annals of Internal Medicine|August 14, 2020
Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care OrganizationSara Y Tartof, Lei Qian, Vennis Hong, et al.
Stroke|November 26, 2015
An International Standard Set of Patient-Centered Outcome Measures After StrokeJoel Salinas, Sara M Sprinkhuizen, Teri Ackerson, et al.
Pageof 49